Moderna, Inc.
MRNA
$27.12
$0.903.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -825.00M | -971.00M | -1.12B | 13.00M | -1.28B |
| Total Depreciation and Amortization | 57.00M | 39.00M | 60.00M | 52.00M | 41.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 146.00M | 106.00M | 148.00M | 98.00M | 110.00M |
| Change in Net Operating Assets | -297.00M | -211.00M | 1.74B | -1.73B | -146.00M |
| Cash from Operations | -919.00M | -1.04B | 825.00M | -1.57B | -1.27B |
| Capital Expenditure | -3.00M | -117.00M | -522.00M | -151.00M | -182.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 567.00M | 847.00M | -17.00M | 872.00M | 1.83B |
| Cash from Investing | 564.00M | 730.00M | -539.00M | 721.00M | 1.65B |
| Total Debt Issued | -2.00M | 2.00M | -4.00M | 3.00M | 1.00M |
| Total Debt Repaid | -3.00M | -- | -10.00M | -- | 1.00M |
| Issuance of Common Stock | 14.00M | 3.00M | 11.00M | 8.00M | 32.00M |
| Repurchase of Common Stock | 0.00 | -1.00M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.00M | 4.00M | -3.00M | 11.00M | 34.00M |
| Foreign Exchange rate Adjustments | 1.00M | -- | -1.00M | 1.00M | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -345.00M | -303.00M | 282.00M | -833.00M | 409.00M |